|
Market Cap (4-Jul) $17,120,630 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.058 |
52w Low $0.021 |
P/E - |
EPS -0.004 |
EMD released this announcement to the ASX on 10 January 2023, 9:28. The announcement is not marked as price sensitive, and is 54 page(s) in length and 10.45MB in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Biotech Showcase San Francisco Presentation | 10 January 2023, 9:28 |
| Notification of cessation of securities - EMD | 5 January 2023, 9:49 |
| Letter to Shareholders/Notice of General Meeting/Proxy Form | 16 December 2022, 13:11 |
| Notice under section 708A(5)(e) of the Corporations Act | 7 December 2022, 18:24 |
You must be logged in to post a reply.
Emyria 